Acute endurance exercise reliably elevates circulating humanin and MOTS-c within minutes of exertion; resistance exercise does not produce the same acute plasma response. Across pooled human studies, exercise-driven MOTS-c rises co-occur with AMPK activation, improved GLUT4 translocation, and reduced HOMA-IR, while humanin increases correlate with attenuated oxidative stress markers — providing a mechanistic bridge between training load and insulin-sensitivity gains.
What Are Mitochondrial-Derived Peptides and Why Does Exercise Activate Them?
Humanin and MOTS-c are small peptides encoded directly within mitochondrial DNA — not the nuclear genome — released into circulation in response to mitochondrial stress. Exercise-induced energetic demand is a primary trigger: ATP depletion and reactive oxygen species generated during sustained aerobic work signal mitochondria to upregulate MDP transcription and secretion, broadcasting metabolic distress to peripheral tissues.
Humanin (21 amino acids) is encoded within the 16S ribosomal RNA region of the mitochondrial genome. MOTS-c (16 amino acids) is encoded within the 12S rRNA region. Both are classified as mitokines — peptide hormones with endocrine reach that extends well beyond the originating cell. Their discovery challenged the long-held assumption that mitochondrial DNA encodes only structural components of the respiratory chain.
The exercise-activation mechanism is tied to mitohormesis: a low-to-moderate mitochondrial stress signal that triggers adaptive, rather than damaging, responses. During aerobic exercise, the AMP:ATP ratio rises sharply, activating AMPK. This energy-sensing kinase is both a downstream target of MOTS-c and an upstream trigger for further MDP secretion, creating a feed-forward loop that amplifies metabolic adaptation across multiple tissues.
Does Endurance Exercise Raise MDP Levels More Than Resistance Training?
Yes — the modality distinction is consistent across human data. Von Walden et al. (2021, Journal of Applied Physiology) found significant post-endurance elevation in plasma humanin and MOTS-c after cycling, with no significant change following a matched resistance protocol. The divergence reflects the sustained oxidative phosphorylation demand unique to aerobic work, not present during glycolytic resistance exercise.
Woodhead et al. (2021, Biochimica et Biophysica Acta) extended this finding by examining skeletal muscle tissue directly, confirming that acute high-intensity endurance exercise increases intramuscular concentrations of both humanin and MOTS-c. The intramuscular signal precedes the plasma rise, consistent with a local autocrine/paracrine action before systemic secretion. Resistance exercise, which relies more heavily on glycolytic flux, does not generate the same mitochondrial oxidative stress signal.
Chronic training status modifies baseline levels. Alser et al. (2022, PMC11273660) compared serum MOTS-c and humanin in professional endurance athletes versus sedentary controls and found that both peptides were significantly altered by chronic training status. Critically, humanin and MOTS-c levels were highly correlated with each other in athletes but not in sedentary individuals — suggesting that coordinated MDP co-secretion is itself a marker of mitochondrial training adaptation.
How Does Exercise-Induced MOTS-c Mechanistically Improve Insulin Sensitivity?
MOTS-c translocates from mitochondria to the nucleus during metabolic stress, where it activates the AMPK–PGC-1α axis and drives GLUT4 translocation to the plasma membrane independent of insulin signaling. This insulin-independent glucose uptake pathway is the core mechanism linking exercise-elevated MOTS-c to improved insulin sensitivity — and explains why MOTS-c is described as an exercise mimetic in the metabolic literature.
Parseh et al. (2024, Diabetes Research and Clinical Practice) conducted an 8-week randomized trial comparing high-intensity versus moderate-intensity exercise in adults with type 2 diabetes. Both exercise intensity groups elevated skeletal muscle MOTS-c, PGC-1α, and GLUT4 protein expression while significantly reducing insulin resistance. The moderate-intensity group showed numerically higher MOTS-c and GLUT4 levels than the high-intensity group, suggesting a non-linear intensity dose-response.
Feng et al. (2025, Biochimica et Biophysica Acta — Molecular Basis of Disease) identified MOTS-c as an upstream regulator of mitochondrial biogenesis — not merely a downstream marker — placing it in a causal rather than correlative role relative to metabolic adaptation. Circulating MOTS-c levels were proposed as a predictive biomarker for aerobic capacity and training-induced metabolic health. This causal framing has significant implications for interpreting exercise-MDP correlations in intervention studies.
What Is Humanin's Distinct Role in Exercise-Linked Insulin Sensitivity?
Humanin signals via a trimeric receptor complex (CNTFR/WSX-1/gp130) to activate STAT3, suppresses hepatic glucose output, and reduces mitochondrial ROS production. Basereh et al. (2025, Scientific Reports) confirmed that aerobic exercise increases circulating humanin and that this rise correlates with improved insulin sensitivity and reduced inflammatory markers in type 2 diabetes, with redox-sensitive miRNAs acting as co-mediators.
The cytoprotective function of humanin is particularly relevant to exercise-induced metabolic stress. By inhibiting NOX2-mediated mitochondrial ROS production and suppressing NLRP3 inflammasome activation, humanin limits the inflammatory signaling that, if unchecked, would impair insulin receptor substrate phosphorylation. This anti-inflammatory brake is mechanistically distinct from MOTS-c's direct GLUT4 trafficking action, meaning the two peptides address insulin resistance through complementary rather than redundant pathways.
Humanin levels decline with aging — a trajectory that mirrors the age-related deterioration of insulin sensitivity and mitochondrial function. The exercise-induced humanin rise may therefore partially explain why regular aerobic training attenuates age-associated insulin resistance beyond what caloric expenditure alone predicts. This aging-exercise-humanin axis remains an active area of investigation, with no long-term RCT data yet available in older adults.
Do MDP Shifts Track Body Composition Changes, Not Just Metabolic Markers?
Cross-sectional data show MOTS-c correlates positively with lean mass and lower-body muscle force. Domin et al. (2023, IJMS) found serum MOTS-c significantly associated with greater muscle mass, jump force, and power output in healthy adults — but not with maximal oxygen uptake, suggesting a muscle-quality rather than cardiorespiratory-fitness signal. This dissociation has direct implications for body-composition tracking in trained populations.
Reynolds et al. (2021, Nature Communications) provided the most direct evidence for MOTS-c as a body-composition regulator: exogenous MOTS-c administration in mice increased lean mass and decreased fat mass, with effects observed across young, middle-aged, and old animals. In humans, the same study documented that circulating MOTS-c rises with exercise and declines with sedentary aging — a pattern that mirrors the lean-mass trajectory across the lifespan. The muscle-targeting property of MOTS-c is attributed to its preferential uptake by skeletal muscle tissue.
Kumagai et al. (2021, PMC8238132) identified myostatin suppression as an additional MOTS-c mechanism relevant to body composition: MOTS-c reduced myostatin expression and downstream atrophy signaling (MuRF-1, MAFbx) in insulin-resistant muscle. Myostatin is a direct negative regulator of muscle mass, so its suppression by exercise-elevated MOTS-c provides a plausible molecular explanation for the lean-mass preservation observed in trained versus sedentary metabolically compromised individuals.
Which Exercise Modalities and Intensities Produce the Largest MDP Response?
Moderate-intensity continuous aerobic exercise (60–70% VO₂max) and high-intensity interval training both elevate plasma MOTS-c and humanin, with the acute response appearing within 30–60 minutes post-exercise. Moderate intensity appears to produce greater sustained MOTS-c elevation than high-intensity protocols in diabetic populations per Parseh et al. (2024), though this intensity inversion requires further investigation in non-diabetic cohorts.
The duration of the acute MDP elevation is not well characterized in humans. Available data from von Walden et al. (2021) captured post-exercise plasma samples at a single time point; the kinetics of return to baseline, the effect of training frequency on trough levels, and the minimum effective exercise dose for a meaningful MDP signal remain unquantified in controlled human trials. These are significant gaps for practitioners attempting to use MDP dynamics as a training-response biomarker.
Yoon et al. (2022, Diabetes & Metabolism Journal) reviewed the mitohormesis framework and noted that exercise training and exogenous MOTS-c administration show additive effects on weight loss and insulin sensitivity in preclinical models — implying that endogenous exercise-driven MDP secretion does not saturate the available receptor capacity. This additive relationship is mechanistically consistent with MOTS-c acting on multiple parallel pathways (AMPK, FOXO, myostatin) rather than a single saturable target.
What Confounders and Evidence Gaps Limit Interpretation of MDP-Exercise Data?
Three confounders dominate: assay heterogeneity across studies (ELISA kits for MOTS-c and humanin are not standardized), absent dietary controls in most exercise trials, and the nonlinear MDP-disease relationship. Yoon et al. (2025, Metabolism) found elevated MOTS-c in obesity — a compensatory signal — underscoring that circulating level alone does not indicate functional receptor engagement.
The human evidence base for MDP-exercise interactions remains largely observational or short-duration interventional. No RCT has randomized participants to exercise conditions with MDP measurement as a primary endpoint alongside gold-standard insulin sensitivity measures (hyperinsulinemic-euglycemic clamp) and DXA-verified body composition. The Kutuk et al. (2026, Scientific Reports) data on reduced MOTS-c in conditions of mitochondrial dysfunction highlight that disease context substantially modifies the exercise-MDP relationship.
Sex and age interact with baseline MDP levels in ways that current exercise studies have not systematically controlled. MOTS-c has been described as an "equal opportunity insulin sensitizer" (Kim et al., 2019) due to sex-independent effects in preclinical models, but human exercise studies have predominantly enrolled male or mixed-sex cohorts without stratified analysis. Aging-associated MDP decline means that the exercise-induced fold-change in older adults may differ substantially from younger cohorts even at identical relative exercise intensities. What Human Safety and Efficacy Data Support MOTS-c for Metabolic or Longevity Indications After the 2026 FDA Review? Does the 2026 Interaction and Sequencing Evidence Support Grouping BPC-157, TB-500, and MOTS-c in a Single Recovery Protocol? Which Outcome Markers Are Most Sensitive for Evaluating NAD+ Plus MOTS-c Cycles in Energy and Recovery Protocols in 2026?